PT-141 can be administered using two different methods: Subcutaneous Injection: Currently, Bremelanotide (PT-141) is administered through a subcutaneous injection, preferably in areas with fat deposits
It is important to note that not everyone may be eligible for tesofensine treatment due to specific health issues
On average, patients may expect to lose an average of 3-4 pounds a month and are typically on the medication for 6-12 months until an ideal weight has been achieved
However, these numbers are not directly comparable retatrutide has 6880-week Phase 3 data while MariTide has 52-week Phase 2 data, and MariTide had not reached a weight plateau at 52 weeks
Many people newly prescribed tirzepatide wonder how long it takes for tirzepatide to work
"However, since these adverse events are reported voluntarily from a population of uncertain size, it is not possible to reliably estimate their frequency," she told Fox News Digital